Table 3.
Groups | Dmax (μm) | Myogenic tone (% of Dmax) | Contraction to PE 10 μM (% of Dmax) | Contraction to high K+ (% of Dmax) |
---|---|---|---|---|
WT | 385±22 | 33±3 | 64±2 | 66±3 |
DL | 399±20 | 16±3* | 64±3 | 61±4 |
DL+IVA | 403±16 | 9±2* | 64±3 | 68±3 |
Abbreviations: DL, dyslipidaemic mice; DL+IVA, dyslipidaemic mice treated with ivabradine; Dmax, maximal diameter; high K+, 40 mM KCl physiological solution; PE, phenylephrine; WT, wild-type mice.
DL+IVA mice were treated with ivabradine (IVA, 10 mg kg−1 day−1) from the age of 3–6 months. Data are mean±s.e.mean. *P<0.05 compared with the WT.